Skip to content

A study to compare efficacy of AGNIMANTH MOOL CHOORNA AND HARIDRAKHANDA CHOORNA in management of SHEETPITTA.(URTICARIA)

â??A RANDOMISED CONTROLLED CLINICAL STUDY OF AGNIMANTH MOOL CHOORNA AND HARIDRAKHANDA CHOORNA IN THE MANAGEMENT OF SHEETPITTA.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043083
Enrollment
30
Registered
2022-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: Agnimanthmool choorna: Agnimanthmool choorna Is Prepared As Per Ayurved Text.Dose-3 gms,Frequency-twice a day,Duration-1 month,Route- oral Control Intervention1: Haridrakhanda Choorna:

Sponsors

CARC Nigdi Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between ages 20-60 yrs irrespective of gender,religion & occupation. Patients having Granthokt lakshanas of sheetpitta

Exclusion criteria

Exclusion criteria: Patients having any associated major illness like 1) Renal failure. 2) Diabetes mellitus. 3) Systemic Lupus Erythematous. 4) Rheumatic disorders. 5) Any type of malignant diseases e.g. Leukaemia metastatic cancer etc. Patient taking treatment from any other pathy for the same problem. Hypersensitivity reactions to any drug.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of AGNIMANTH MOOL CHOORNA AND HARIDRAKHANDA CHOORNA in the management of Sheetpitta(Urticaria).Timepoint: 30 Days on follow up on 7 days.

Secondary

MeasureTime frame
To Study The Side Effects of Drug If Any.Timepoint: 30 Days

Countries

India

Contacts

Public ContactDR YOGENDRA YASHWANT MORE

PDEAs College of Ayurveda And Research Centre Akurdi Pune

khobragaderupali19@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026